Risk factor analysis and treatment strategies for oral implant restoration in patients with Sjögren syndrome

doi:10.12337/zgkqzzxzz.2024.08.005

Abstract

Abstract: Sjögren syndrome (SS) is a common disease in oral clinical practice with typical symptoms such as dry mouth and dry eyes, often accompanied by complex systemic symptoms and a long history of medication. With the growing prevalence of dental implant restorations, there has been a corresponding rise in the demand for implantation treatments among individuals with Sjögren Syndrome. However, there is a lack of relevant treatment guidelines for implant restoration in these patients. This article presents a case of an implant-supported fixed complete dental prosthesis in a patient with Sjögren syndrome,summarizes our team's experience in the treatment of implant restoration in these patients, and discusses the risk assessment and treatment strategies for dental implant restorations in patients with Sjögren syndrome. A comprehensive risk assessment before treatment, a reasonable implant restoration plan, and consistent long-term plaque control are essential for the successful outcomes of implant restorations in patients with Sjögren syndrome.

Key words: Sjögren syndrome, Dental implant, Risk factors, Treatment protocols

Chen Li, Fang Ming, Zhang Yanting, Zhang Xiaolin, Liu Qing, Zheng Zhaohui, Zhou Wei. Risk factor analysis and treatment strategies for oral implant restoration in patients with Sjögren syndrome[J]. Chinese Journal of Oral Implantology, 2024, 29(4): 320-327.

References

[1] Akin R K, Kreller A J, Walters P J, et al.Sjögren's syndrome[J].Plastic Reconstructive Surg, 1975, 56(4):462.
[2] Atkinson JC, Fox PC. Sjögren's syndrome: oral and dental considerations[J]. J Am Dent Assoc, 1993,124(3):74-76, 78-82, 84-86. DOI: 10.14219/jada.archive.1993.0064.
[3] Margaix-Muoz M, José V Bagán, Poveda R,et al.Sjögren's syndrome of the oral cavity. Review and update[J].Med Oral Patol Oral Cir Bucal, 2009, 14(7):e325-e330.
[4] Fox R, Howell F.Oral problems in patients with Sjögren's syndrome[J].Scandinavian journal of rheumatology. Supplement, 1986, 61:194-200. DOI:10.1111/j.1365-3083.2006.01811.x.
[5] Le Gall M, Cornec D, Pers JO, et al.A prospective evaluation of dental and periodontal status in patients with suspected Sjögren's syndrome[J]. Joint Bone Spine, 2016,83(2):235-236. DOI: 10.1016/j.jbspin.2015.02.015.
[6] Tanaka A, Kellesarian SV, Arany S.Xerostomia and patients' satisfaction with removable denture performance: systematic review[J]. Quintessence Int, 2021,52(1):46-55. DOI: 10.3290/j.qi.a45427.
[7] Ginesin O, Mayer Y, Gabay E, et al.Revealing leukocyte populations in human peri-implantitis and periodontitis using flow cytometry[J]. Clin Oral Investig, 2023,27(9):5499-5508. DOI: 10.1007/s00784-023-05168-y.
[8] Jin L, Dai M, Li C, et al.Risk factors for primary Sjögren's syndrome: a systematic review and meta-analysis[J]. Clin Rheumatol, 2023,42(2):327-338. DOI: 10.1007/s10067-022-06474-8.
[9] Donos N, Calciolari E.Dental implants in patients affected by systemic diseases[J]. Br Dent J, 2014,217(8):425-430. DOI: 10.1038/sj.bdj.2014.911.
[10] Ramos-Casals M, Brito-Zerón P, Bombardieri S, et al.EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies[J]. Ann Rheum Dis, 2020,79(1):3-18. DOI: 10.1136/annrheumdis-2019-216114.
[11] 王倩, 戴生明. 《2019年欧洲抗风湿病联盟干燥综合征局部与系统性治疗推荐》解读[J].中华临床免疫和变态反应杂志,2020,14(3):179-182. DOI: 10.3969/j.issn.1673-8705.2020.03.001.
[12] Ramos-Casals M, Brito-Zerón P, Bombardieri S, et al.EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies[J]. Ann Rheum Dis, 2020,79(1):3-18. DOI: 10.1136/annrheumdis-2019-216114.
[13] Furness S, Bryan G, McMillan R, et al. Interventions for the management of dry mouth: non-pharmacological interventions[J]. Cochrane Database Syst Rev, 2013,2013(9):CD009603. DOI: 10.1002/14651858.CD009603.pub3.
[14] Ramos-Casals M, Tzioufas AG, Stone JH, et al.Treatment of primary Sjögren syndrome: a systematic review[J]. JAMA, 2010,304(4):452-460. DOI: 10.1001/jama.2010.1014.
[15] Bornstein MM, Cionca N, Mombelli A.Systemic conditions and treatments as risks for implant therapy[J]. Int J Oral Maxillofac Implants, 2009,24(Suppl):12-27.
[16] Ozen G, Pedro S, Wolfe F, et al.Medications associated with fracture risk in patients with rheumatoid arthritis[J]. Ann Rheum Dis, 2019,78(8):1041-1047. DOI: 10.1136/annrheumdis-2019-215328.
[17] Chochlidakis K, Ercoli C, Elad S.Challenges in implant-supported dental treatment in patients with Sjögren's syndrome: a case report and literature review[J]. Quintessence Int, 2016,47(6):515-524. DOI: 10.3290/j.qi.a36009.
[18] 邢海霞, 王琳, 潘洁, 等. 干燥综合征患者口腔种植修复的临床策略[J].中国口腔医学继续教育杂志,2023, 26(4):240-246. DOI: 10.12337/zgkqjxjyzz. 2023.04.002.
[19] Goodman SM, Springer BD, Chen AF, et al.2022 american college of rheumatology/american association of hip and knee surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty[J]. Arthritis Care Res (Hoboken), 2022,74(9):1399-1408. DOI: 10.1002/acr.24893.
[20] Chrcanovic BR, Kisch J, Wennerberg A.Dental implants in patients with Sjögren's syndrome: a case series and a systematic review[J]. Int J Oral Maxillofac Surg, 2019, 48(9): 1250-1259
[21] 罗翠芬, 彭国光, 冯远华, 等. 干燥综合征患者牙种植1例[J].华西口腔医学杂志,2017,35(1):108-111. DOI: 10.7518/hxkq.2017.01.018.
[22] 孟迅吾,徐苓.骨质疏松症和骨矿盐疾病诊疗指南[C].中国骨质疏松与骨矿盐疾病诊疗指南专题研讨班暨浙江省骨质疏松与骨矿盐疾病防治进展学术年会论文汇编.杭州: 2007.
[23] Duru N, van der Goes MC, Jacobs JW, et al. EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases[J]. Ann Rheum Dis, 2013,72(12):1905-1913. DOI: 10.1136/annrheumdis-2013-203249.
[24] Korfage A, Raghoebar GM, Arends S, et al.Dental implants in patients with Sjögren's syndrome[J]. Clin Implant Dent Relat Res, 2016,18(5):937-945. DOI: 10.1111/cid.12376.
[25] Chrcanovic BR, Kisch J, Wennerberg A.Dental implants in patients with Sjögren's syndrome: a case series and a systematic review[J]. Int J Oral Maxillofac Surg, 2019,48(9):1250-1259.
[26] Hashimoto H, Hashimoto S, Muto A, et al.Influence of plaque control on the relationship between rheumatoid arthritis and periodontal health status among japanese rheumatoid arthritis patients[J]. J Periodontol, 2018,89(9):1033-1042. DOI: 10.1002/JPER.17-0575.
[27] 风湿免疫病慢病管理全国护理协作组. 干燥综合征护理管理专家共识[J].护理管理杂志,2021,21(4):265-270,275. DOI: 10.3969/j.issn.1671-315x.2021.04.008.